Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PHN.MIthis companyPharmanutra S.p.A.	€75.30	25.98×	7.28×	3.95×	15.25×	-11.0%	22.6%	23.0%	15.2%	28.0%	20.1%	3.2%	0.29×	0.06×	27.86×	2.35×	1.8%	5	9.31	3	B
ARBS.MIArterra Bioscience	€2.98	10.07×	1.6×	4.32×	21.57×	31.3%	15.9%	12.7%	43.2%	15.9%	4.3%	7.7%	0.02×	-1.23×	667.15×	7.74×	4.2%	6	6.82	4	A+
ELN.MIEL.En. S.p.A.	€16.11	25.78×	2.71×	1.89×	11.54×	-45.6%	42.9%	12.2%	7.3%	10.5%	10.2%	5.4%	0.09×	-1.61×	37.19×	3.1×	1.7%	6	6.93	4	A-
EUK.MIEuKedos S.p.A.	€0.48	-21.43×	0.55×	0.31×	14.02×	947.7%	23.4%	8.7%	-1.5%	-2.6%	2.8%	2.7%	4.41×	12.46×	0.81×	0.21×	0.0%	5	0.29	2	B-
OTO.MIOtofarma S.p.A.	€2.16	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
PHIL.MIPhilogen S.p.A.	€21.15	4.09×	2.51×	2.99×	3.21×	-1253.1%	86.5%	80.0%	73.1%	61.4%	57.4%	28.6%	0.03×	-0.45×	760.06×	7.76×	0.0%	7	9.45	4	A
Peer median	—	7.08×	2.05×	2.44×	12.78×	-7.1%	33.2%	12.5%	25.2%	13.2%	7.2%	6.5%	0.06×	-0.84×	352.17×	5.42×	0.8%	6	6.87	4	—